Argentine molecular biology institute specializing in intrinsically disordered proteins, structural prediction, and biochemical research since 1947.
The Fundación Instituto Leloir is a leading independent research institute in Buenos Aires, Argentina, specializing in molecular biology, biochemistry, and structural biology. Named after Nobel laureate Luis Federico Leloir, the institute conducts fundamental research into how proteins work at a molecular level — including the highly challenging class of proteins that lack a fixed structure (intrinsically disordered proteins, or IDPs). Their H2020 participation shows two distinct research threads: plant biochemistry and signaling, and computational approaches to characterizing protein function using databases, predictive tools, and structured ontologies. As a third-party participant in MSCA-RISE exchanges, they contribute primarily by hosting and sending researchers rather than leading project administration.
IDPfun (2018–2023) focused specifically on functional characterization of IDPs, with keywords spanning databases, prediction, and ontology — indicating both wet-lab and computational contributions.
IDPfun keywords include 'prediction', 'databases', and 'ontology', pointing to bioinformatics tooling and classification work alongside experimental research.
SIGNAT (2015–2019) addressed evaluation of plant signaling networks in natural environments, reflecting broader biochemical expertise beyond mammalian systems.
Both H2020 projects are MSCA-RISE schemes, meaning the institute's consistent role is hosting and dispatching researchers as part of international mobility programs.
In their first H2020 project (SIGNAT, 2015–2019), the institute engaged in plant biology — studying signaling networks in environmental contexts, which reflects a classical biochemistry tradition. By their second project (IDPfun, 2018–2023), the focus had shifted markedly toward protein structural biology and bioinformatics: specifically the prediction and ontological classification of intrinsically disordered proteins, a field that sits at the intersection of computational biology and experimental biochemistry. The trend suggests a deliberate move from organism-level plant science toward molecular-scale protein science enriched by computational tools and curated databases.
The institute is moving toward computational structural biology — specifically the growing field of intrinsically disordered proteins, which is highly relevant to drug target discovery and disease research — making them an increasingly attractive partner for consortia in structural bioinformatics or translational biology.
Fundación Instituto Leloir has participated exclusively as a third-party contributor in MSCA-RISE projects, meaning they join established consortia to facilitate researcher mobility rather than driving project design or coordination. With 13 unique partners across 10 countries from just 2 projects, they are connected to relatively large, international networks — consistent with the MSCA-RISE format, which typically involves 6–15 partner institutions. Working with them means accessing an internationally connected Argentine research hub willing to host visiting researchers and contribute domain expertise, but not expecting administrative leadership.
The institute has built connections with 13 unique partner organizations across 10 countries through just 2 projects, reflecting the broad consortium structure typical of MSCA-RISE exchanges. Their reach is genuinely global — connecting a South American institute with European research networks.
Instituto Leloir is one of Argentina's most prestigious research institutes, with a 70-year legacy in biochemistry and a Nobel Prize in its founding heritage — making it the rare non-European H2020 participant that brings genuine scientific authority rather than just geographic diversity. For consortia needing a Latin American research partner with deep expertise in molecular biology and protein science, they offer credibility that few other South American institutions can match. Their combination of experimental biochemistry tradition and emerging computational biology capability makes them a bridge between classical wet-lab research and modern bioinformatics approaches.
